Page 160«..1020..159160161162..170180..»

Mount Sinai partners with Chiba Institute on AI for cardiovascular … – Healthcare IT News

Posted: Published on October 16th, 2023

The Icahn School of Medicine at Mount Sinai has signed a memorandum of understanding with the Chiba Institute of Technology to use artificial intelligence to enhance clinical trials for cardiovascular disease, advance patient care and bring potential new treatments to heart disease patients more quickly. WHY IT MATTERS The affiliation between the two institutions aims to develop new strategies leveraging artificial intelligence to prevent and enhance the treatment of cardiovascular disease, a global health challenge, according to an announcement from Mount Sinai. Dr Continue reading

Posted in Interventional Cardiology | Comments Off on Mount Sinai partners with Chiba Institute on AI for cardiovascular … – Healthcare IT News

Amylyx Pharmaceuticals Receives Negative CHMP Opinion on its … – Amylyx

Posted: Published on October 16th, 2023

- PHOENIX Phase 3 trial topline results on track for mid-2024 and will inform regulatory next steps in the EU - Final decision from the European Commission expected by the end of 2023 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. Continue reading

Posted in ALS Treatment | Comments Off on Amylyx Pharmaceuticals Receives Negative CHMP Opinion on its … – Amylyx

Interferon-gamma therapy may help delay familial ALS: Cell study … – ALS News Today

Posted: Published on October 16th, 2023

People with amyotrophic lateral sclerosis (ALS) due to mutations in the FUS gene may benefit from interferon-gamma treatment to delay disease onset and/or progression, an early preclinical study suggests. Researchers found that an immune signaling protein called interferon (INF)-gamma protected patient-derived motor neurons from oxidative stress Continue reading

Posted in ALS Treatment | Comments Off on Interferon-gamma therapy may help delay familial ALS: Cell study … – ALS News Today

New EAP will allow pridopidine use for ALS patients not in trial |… – ALS News Today

Posted: Published on October 16th, 2023

Amyotrophic lateral sclerosis (ALS) patients not eligible to participate in clinical trials of pridopidine a small molecule developed by Prilenia Therapeutics to slow disease progression in ALS will soon be able to receive the experimental therapy via an expanded access program (EAP). EAPs, also known as compassionate-use programs, are aimed at people with serious or life-threatening conditions that have few or no adequate treatments. Continue reading

Posted in ALS Treatment | Comments Off on New EAP will allow pridopidine use for ALS patients not in trial |… – ALS News Today

Finding Hope – Hood County News

Posted: Published on October 16th, 2023

Heather Cleveland Heather Cleveland shares about her diagnosis, next weekends fundraiser and hope for a cure Heather Cleveland has been a staple of the Granbury scene for decades both as a businesswoman, and as an involved participant in the local art scene. Cleveland was diagnosed with Amyotrophic Lateral Sclerosis (ALS) in May 2021 Continue reading

Posted in ALS Treatment | Comments Off on Finding Hope – Hood County News

Under attack: Israel’s national EMS treat the wounded under fire – EMS1.com

Posted: Published on October 16th, 2023

Magen David Adom (MDA), is a national EMS organization on the front lines of the war. On the morning of October 7, 30 minutes before the night shift was about to end, MDA emergency phone operators began receiving calls of injuries along the Gaza strip and the settlements of the Western Negev, under the cover of rocket barrages. Continue reading

Posted in ALS Treatment | Comments Off on Under attack: Israel’s national EMS treat the wounded under fire – EMS1.com

Light sheet fluorescence microscopy of cleared human eyes … – Nature.com

Posted: Published on October 16th, 2023

Eye samples Eye samples from donors were obtained through the Lions Gift of Sight (Saint Paul Minnesota, USA), operating under the regulations of the U.S. Food and Drug Administration (FDA) and the Eye Bank Association of America. Consent from the donor was obtained and the next of kin received no charge or monetary gain from the donation Continue reading

Posted in Batten Disease Treatment | Comments Off on Light sheet fluorescence microscopy of cleared human eyes … – Nature.com

Efficacy of Poria cocos and Alismatis rhizoma against diet-induced … – Nature.com

Posted: Published on October 16th, 2023

Animals Fifty 6-week-old male SpragueDawley (SD) rats were obtained from the Experimental Animal Science and Technology Development Co., Ltd., affiliated with Southern Medical University (license number: SCXK 2011-0015). The rats were housed in an SPF-grade barrier environment at an ambient temperature of 2125 with 5060% humidity and maintained on a 12-h light/12-h dark cycle in the Laboratory Animal Center of Guangzhou University of Chinese Medicine (Guangzhou, China) Continue reading

Posted in Batten Disease Treatment | Comments Off on Efficacy of Poria cocos and Alismatis rhizoma against diet-induced … – Nature.com

Molybdenum Target X-ray in Early Breast Carcinoma Diagnosis … – Dove Medical Press

Posted: Published on October 16th, 2023

Introduction Breast carcinoma (BC), a common heterogeneous tumor that threatens womens physical and mental health all over the world, is influenced by age, obesity, smoking, alcohol consumption, family history, and use of oral contraceptives.13 Worldwide, there are approximately 2.1 million females diagnosed as BC each year and 630,000 associated deaths.4 Early diagnosis of BC, of no doubt, is conducive to improving survival outcomes and the probability of successful treatment in such patients.5 Moreover, early monitoring is of great value in understanding BC progression and predicting the treatment response, allowing for effective and timely adjustment of treatment.57 Thus, exploring the early diagnosis of BC is beneficial to reduce mortality in BC patients and improve the chance of survival. Molybdenum target X-ray is an imaging technique that uses molybdenum target X-ray machine to take pictures of the patients breast in oblique and axial planes, which can obtain information about the shape, margin, density, calcification and axillary lymph nodes (LNs) of the patients breast mass.8 This examination technique has the advantages of non-invasiveness and high resolution, with important guiding value in early diagnosis and prognosis evaluation of BC.9 But it also has some shortcomings such as poor penetrability and difficulty in distinguishing deep and high lesions, which limits its diagnostic accuracy (ACC) in breast lesions and pathological properties.10,11 High-frequency color Doppler flow imaging (CDFI) is another imaging inspection system that collects information such as the location, size, relationship with surrounding tissues and blood flow of the lesions by examining the lesions in different planes of the breast, which can effectively determine the nature of the lesions and distinguish the benign and malignant breast tumors.12,13 This technique can also be applied to assess the response of tumor xenografts in nude mice to early antiangiogenic therapy.14 Its drawbacks lie in the difficulty in distinguishing small lesions with unclear echoes and microcalcifications (MCs), as well as the difficulty in screening for ductal carcinoma in situ.15 Molybdenum target X-ray has good diagnostic ability for early lesion morphology and microcalcification foci of BC, which can just make up for the shortcomings of CDFI.16 Therefore, we believe that the combination of the two may have a synergistic effect on the early diagnosis of BC. Continue reading

Posted in Batten Disease Treatment | Comments Off on Molybdenum Target X-ray in Early Breast Carcinoma Diagnosis … – Dove Medical Press

Resting metabolic rate is increased after a series of whole body … – Nature.com

Posted: Published on October 16th, 2023

Study design The study was a parallel randomized trial. Thirty-two healthy men between the aged 21 to 23years old were recruited and randomly assigned to two 16-member groups: a group participating in the WBV intervention (n=16) and a group without the intervention (placebo: PL, n=16) Continue reading

Posted in Batten Disease Treatment | Comments Off on Resting metabolic rate is increased after a series of whole body … – Nature.com

Page 160«..1020..159160161162..170180..»